Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/37877Registo completo
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.contributor.author | Rodrigues, Célia Fortuna | por |
| dc.contributor.author | Gonçalves, Bruna | por |
| dc.contributor.author | Rodrigues, E. | por |
| dc.contributor.author | Silva, Sónia Carina | por |
| dc.contributor.author | Azeredo, Joana | por |
| dc.contributor.author | Henriques, Mariana | por |
| dc.date.accessioned | 2015-10-30T17:36:06Z | - |
| dc.date.available | 2015-10-30T17:36:06Z | - |
| dc.date.issued | 2015-10-09 | - |
| dc.identifier.citation | Rodrigues, Célia F.; Gonçalves, B.; Rodrigues, E.; Silva, Sónia Carina; Azeredo, Joana; Henriques, Mariana, Fluconazole vs Voriconazole: Candida glabratas biofilms response to different azoles. 7th Trends in Medical Mycology. Vol. Mycoses 58(Suppl. 4), Lisbon, Portugal, 9-12 Oct, 78-78, 2015. | - |
| dc.identifier.issn | 0933-7407 | por |
| dc.identifier.uri | https://hdl.handle.net/1822/37877 | - |
| dc.description.abstract | Candida glabrata is the second most prevalent yeast in fungal infections, especially in immunocompromised and/or hospitalized patients. The azole resistance within this species is very well-known and results in a low therapeutic response of C. glabrata infections, particularly when associated with biofilms. Objective - To understand the different efficacies of two azoles against C. glabrata biofilms: - fluconazole (Flu), a long time used drug - voriconazole (Vcz), a latest drug used only in hospitals. | por |
| dc.description.sponsorship | Programa Operacional, Fatores de competitividade – COMPETE and by national funds through FCT – Fundação para a Ciência e a TecnologiaonthescopeoftheprojectsFCT PTDC/SAU-MIC/119069/2010, RECI/EBB- EBI/0179/2012, PEst-OE/EQB/LA0023/2013 Project “BioHealth - Biotechnology and Bioengineering approachesto improvehealthquality",Ref. NORTE-07-0124-FEDER-000027, co-funded by the Programa Operacional Regional do Norte (ON.2 – O Novo Norte), QREN, FEDER | por |
| dc.language.iso | eng | por |
| dc.publisher | John Wiley and Sons | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/5876-PPCDTI/119069/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/5876-PPCDTI/126270/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/COMPETE/126270/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/3599-PPCDT/132966/PT | - |
| dc.relation | info:eu-repo/grantAgreement/FCT/COMPETE/119069/PT | - |
| dc.rights | openAccess | por |
| dc.subject | Candida glabrata | por |
| dc.subject | Biofilms | por |
| dc.subject | Resistance mechanisms | por |
| dc.subject | Antifungals | por |
| dc.subject | Matrix | por |
| dc.title | Fluconazole versus Voriconazole: Candida glabrata biofilms response to different azoles | por |
| dc.type | conferenceAbstract | - |
| dc.peerreviewed | yes | por |
| dc.relation.publisherversion | http://onlinelibrary.wiley.com/doi/10.1111/myc.12380/abstract | por |
| dc.comments | CEB23432 | por |
| sdum.publicationstatus | published | por |
| oaire.citationConferenceDate | 9 Out. - 12 Out. 2015 | por |
| sdum.event.type | conference | por |
| oaire.citationStartPage | 78 | por |
| oaire.citationEndPage | 78 | por |
| oaire.citationIssue | Suppl. 4 | - |
| oaire.citationConferencePlace | Lisbon, Portugal | por |
| oaire.citationTitle | 7th Trends in Medical Mycology | por |
| oaire.citationVolume | Mycoses 58 | - |
| dc.date.updated | 2015-10-14T20:52:01Z | - |
| dc.subject.fos | Ciências Médicas::Biotecnologia Médica | por |
| dc.subject.wos | Science & Technology | por |
| sdum.journal | Mycoses | por |
| Aparece nas coleções: | ||
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| document_23432_1.pdf | 63,85 kB | Adobe PDF | Ver/Abrir | |
| document_23432_2.pdf | 1,26 MB | Adobe PDF | Ver/Abrir |
